Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Interstitial Lung Disease, An Issue of Immunology and Allergy Clinics of North America
- 1st Edition, Volume 43-2 - April 17, 2023
- Editors: Kevin K Brown, Joshua J. Solomon
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 1 8 1 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 1 8 2 - 5
In this issue of Immunology and Allergy Clinics, guest editors Joshua Solomon and Kevin Brown bring their considerable expertise to the topic of Interstitial Lung Disease. Top… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Immunology and Allergy Clinics, guest editors Joshua Solomon and Kevin Brown bring their considerable expertise to the topic of Interstitial Lung Disease. Top experts address topics such as IPF and other PF-ILDs, Post-Covid ILD, CTLD-ILD, Sarcoidosis, and more.
-
Contains 14 practice-oriented topics including Pulmonary Vasculitis and Alveolar Hemorrhage; Eosinophilic Interstitial Lung Diseases; Occupational Lung Disease; Smoking-related ILD; LAM and other cystic lung diseases; and more.
-
Provides in-depth clinical reviews of interstitial lung disease, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Immunologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
- Key points
- Idiopathic pulmonary fibrosis
- Other interstitial lung diseases—progressive pulmonary fibrosis
- Clinics care points
- Funding
- Conflict of interest disclosures
- Connective Tissue Disease Associated Interstitial Lung Disease
- Key points
- Introduction
- Epidemiology and clinical outcomes
- Therapeutic options and advances
- Pathogenic pathways in connective tissue disease associated interstitial lung disease
- Subclinical disease
- Research agenda
- Summary
- Clinics care points
- Declaration of Interests
- Hypersensitivity Pneumonitis: Updates in Evaluation, Management, and Ongoing Dilemmas
- Key points
- Introduction
- Epidemiology
- Pathogenesis
- Clinical characteristics
- Management
- Summary
- Clinics care points
- Disclosures
- Sarcoidosis
- Key points
- Introduction
- Epidemiology
- Pathology, pathogenesis, and potential etiologic factors
- Diagnostic approach
- Clinical manifestations
- Extrapulmonary Manifestations
- Systemic manifestations
- Treatment
- Follow-up and prognosis
- Summary
- Clinics care points
- Disclosure
- Smoking-Related Interstitial Lung Diseases
- Key points
- Introduction
- Pulmonary Langerhans cell histiocytosis
- Respiratory bronchiolitis-interstitial lung disease
- Desquamative interstitial pneumonia
- Acute eosinophilic pneumonia
- Combined pulmonary fibrosis and emphysema
- Other interstitial lung disorders
- Summary
- Clinics care points
- Disclosure
- Eosinophilic Lung Diseases
- Key points
- Definition and classification
- Pathophysiology
- Idiopathic chronic eosinophilic pneumonia
- Idiopathic and smoking-related acute eosinophilic pneumonia
- Eosinophilic granulomatosis with polyangiitis
- Allergic bronchopulmonary aspergillosis
- Other eosinophilic lung diseases
- Practical approach to diagnosis and treatment
- Clinics care points
- Occupational Interstitial Lung Diseases
- Key points
- Introduction
- Occupational interstitial lung diseases
- Occupational Burden of Other Interstitial Lung Diseases
- Limitations of the Evidence and Future Research Directions
- Summary
- Clinics care points
- Disclosures
- Author contributions
- Drug-Induced Interstitial Lung Diseases
- Key points
- Introduction
- Epidemiology
- Pathogenesis and risk factors
- Clinical presentation
- Diagnosis
- Implicated drugs
- Management, treatment, and prognosis
- Discussion
- Summary
- Clinics care points
- Disclosure
- Lymphangioleiomyomatosis and Other Cystic Lung Diseases
- Key points
- Introduction
- Definition
- Lymphangioleiomyomatosis
- Birt-Hogg-Dubé
- Lymphoid interstitial pneumonia
- Amyloidosis and light chain deposition
- Pulmonary Langerhans cell histiocytosis
- Summary
- Clinics care points
- Disclosure
- Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis: A Review
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Disclosure
- Post-COVID Interstitial Lung Disease—The Tip of the Iceberg
- Key points
- Introduction
- Pathophysiology of post-COVID interstitial lung disease
- Persistent symptoms post-COVID
- Summary
- Clinics care points
- Disclosure
- Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease
- Key points
- Introduction
- Blood-based diagnostic biomarkers
- Blood-based prognostic biomarkers
- High-resolution computed tomography: connective tissue disease-interstitial lung disease diagnosis and prognosis
- Radiomics and quantitative high-resolution computed tomography
- Unmet research needs and strategies for biomarker optimization
- Summary
- Clinics care points
- Funding
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 43-2
- Published: April 17, 2023
- Imprint: Elsevier
- Hardback ISBN: 9780443181818
- eBook ISBN: 9780443181825
KB
Kevin K Brown
Affiliations and expertise
National Jewish HealthJS
Joshua J. Solomon
Affiliations and expertise
Director, Interstitial Lung Disease Program, Associate Professor, Department of Medicine Division of Pulmonary, Critical Care & Sleep ,Medicine Section of Critical Care Medicine, National Jewish Health